We will not be posting today in commemoration of Labor Day. We’ll be back to our regular schedule tomorrow, Tuesday, September 2nd.
Wolters Kluwer Holiday
September 1, 2014 by
Health | Wolters Kluwer Legal & Regulatory U.S.
Health & the Law, Analysis and Information
FDA Press Releases
- Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths January 17, 2019
- FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy January 16, 2019
- Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies January 15, 2019
- Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations January 7, 2019